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Global importance: Leptospirosis is the most widespread zoonosis worldwide. Mammals  
(eg, rats, horses, cows, pigs, dogs, cats and aquatic species, such as sea lions and northern 
elephant seals) can all be infected by leptospires. Infection in animals occurs through contact 
with urine or water contaminated with the bacteria. In people, the disease is acquired mainly 
from animal sources or through recreational activities in contaminated water. 
Practical relevance: Literature on the clinical presentation of leptospirosis in cats is scarce, 
although it has been demonstrated that cats are susceptible to infection and are capable of 
developing antibodies. The prevalence of antileptospiral antibodies in cats varies from 4% to 33.3% 
depending on the geographical location. Urinary shedding of leptospires in naturally infected cats has  
been reported, with a prevalence of up to 68%. Infection in cats has been associated with the consumption 
of infected prey, especially rodents. Thus, outdoor cats have a higher risk of becoming infected.  
Clinical challenges: Clinical presentation of this disease in cats is rare and it is not known what role cats 
have in the transmission of leptospirosis. Ongoing work is needed to characterise feline leptospirosis. 
Audience: This review is aimed at all veterinarians, both general practitioners who deal with cats on a daily 
basis in private practice, as well as feline practitioners, since both groups face the challenge of diagnosing 
and treating infectious and zoonotic diseases. 
Evidence base: The current literature on leptospirosis in cats is reviewed. To date, few case reports have 
been published in the field, and information has mostly been extrapolated from infections in people and 
dogs. This review is expected to serve as a guide for the diagnosis and management of the disease in cats. 
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C L I N I C A L  R E V I E W
Aetiology 
 
Leptospirosis is caused by spirochetal bac teria 
of the genus Leptospira. These are highly 
motile, elongated and helically coiled bac -
teria that differ morphologically from other  
spirochetes by having a ‘question mark’ or 
hook-shaped end.1–3 The genus Leptospira  
was originally divided into two species: 
Leptospira­ interrogans, containing the patho -
genic serovars, and Lepto­spira­biflexa, contain-
ing the non-pathogenic saprophytic serovars.4 
However, this phenotypic classification has 
been largely superseded by genetic classi -
fication, based on genotypic identification 
techniques, that includes all serovars of  
L­interrogans­sensu lato and L­biflexa­sensu lato 
(sensu lato is a Latin phrase meaning ‘in the 
broad sense’ and is often used taxonomically 
to indicate a species complex).3  
Currently, 22 species of Leptospira have  
been identified;4 at least 10 of these are 
pathogenic. There are also seven saprophytic 
species and five species of indeterminate 
pathogenicity.5 It is likely that more species 
will be described in the future. Pathogenic 
Leptospira species are divided into serovars, 
each with distinct antigenic compositions; to 
date, over 260 pathogenic serovars, arranged 
into 26 serogroups, have been identified. This 
serological classification, based on determin-
ing antigenic characteristics, is more useful 
diagnostically and also better serves epidemi-
ological purposes. 
All mammals may be susceptible to Lepto­-
spira­infection.3 There are primary (definitive) 
or carrier hosts for some serovars (eg, dogs  
are hosts for Canicola; cows and sheep for  
Hardjo; pigs for Pomona and Brat islava;  
and rats for Ictero haemorrhagiae and Copen -
hageni). These contribute to a greater extent to 
the spread of bacteria in the environment 
compared with incidental or dead-end hosts 
(ie, that suffer acute disease and are unlikely 
to serve as a source of transmission; eg, 
humans). The definitive host is typically infect-
ed at a young age and commonly exhibits 
minimal clinical disease, whereas animals 
infected with non-host-adapted serovars are 
expected to exhibit more severe clinical signs.3 
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Epidemiology 
 
Leptospirosis is endemic in almost all regions 
of the world.2 Its incidence usually increases 
at the end of the summer months, while  
in the tropics most infections occur during 
and after periods of rainfall.1,2 Pathogenic 
Leptospira­ species experience optimal growth 
at temperatures of 28–30ºC. Although they do 
not replicate outside of the host, they can sur-
vive for months in moist soil saturated with 
urine,1,3 and this can lead to significant envi-
ronmental contamination. In people, there  
are three main factors associated with the risk 
of disease transmission: (1) water exposure; 
(2) exposure to carrier rodents; and (3) trans-
mission from livestock or pets.6  
Feline leptospirosis was first described in 
1972,7 and prevalence studies show the main 
serovars belong to serogroups Australis, 
Autumnalis, Canicola and Sejroe,8–18 although 
there are geographical variations. The most 
frequent serovars involved in feline lepto -
spirosis in Europe – according to the European 
consensus statement on leptospirosis, and 
based on the prevalence of antibodies mea-
sured by the microscopic agglutination test 
(MAT) – belong to serogroups Australis, 
Autumnalis, Ballum, Canicola, Grippo typhosa, 
Ictero haemorrhagiae, Pomo na and Sejroe.19 
The most commonly reported serovars in cats 
in the USA belong to serogroups Australis, 
Autumnalis, Grippo typhosa and Pomona.8,20 
Figure 1 shows the countries where the preva-
lence of leptospirosis in cats has been report-
ed, based on MAT and/or urinary and  
blood PCR. Table 1 summarises previous 
research on feline leptospirosis prevalence  
by MAT diagnosis. Overall seropositivity 
reported in these studies ranged from 4%  
to 33.3%, with no clear association with clini-
cal disease. 
Leptospiral infection in cats has been associ-
ated with the consumption of infected prey,29 
involving serovars of the Autumnalis and 
Ballum serogroups.3 Outdoor cats have an 
increased risk of becoming infected with lep-
tospires since they are in close contact with 
reservoir hosts. In rural areas, cats can also 
become infected via urine from pigs and 
cows.12,15,28–30 The presence of another cat in 
the household significantly increases the risk 
of seropositivity for lepto spirosis.14  
At present, it is not completely understood 
which serovars cause incidental infections  
in cats. Based on previously published  
reports of acute leptospirosis in cats, serovars 
belonging to Autumnalis, Australis, Ictero -
haemorrhagiae, Grippotyphosa, Pomona  
and Sejroe serogroups are involved.14,18,30–32 
Several studies have confirmed renal carriage 
of Leptospira species by PCR, and these  
cats had antibodies mainly against serovars 
belonging to Australis, Canicola, Ictero -
haemorrhagiae and Pomona serogroups. 
Given this fact, cats could be a chronic reser-
voir host for the bacteria and a possible risk 
factor for human infection.10,11,13,14,16,26,30,33,34 
Outdoor  
cats have  
an increased 
risk of 
leptospirosis, 
through 
contact with 
reservoir 
hosts. 
At present, it is 
not completely 
understood 
which serovars 
cause 
incidental 
infections in 
cats and which 
have developed 
adaptation to 
feline species. 
Figure 1 Map indicating (in red) the countries where the prevalence of leptospirosis in cats has been reported, based on 
microscopic agglutination test (MAT) and/or urinary and blood PCR 
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Location n Positive serovar(s) Negative serovar(s) Prevalence (%) Reference
Malaysia – Johor and 
Selangor
110 Ballum, Bataviae*, 
Copenhageni and Javanica 
Australis, Autumnalis, Canicola, Celledoni, Cynopteri, 
Djasiman, Grippotyphosa, Hardjo, Hardjo-bovis, 
Hebdomadis, Icterohaemorrhagiae, Lai, Malaysia,  
Pomona, Pyrogenes and Tarassovi
18.1 9
Thailand – 13 locations 260 Anhoa, Autumnalis, Celledoni, 
Copenhageni, Djasiman, 
Icterohaemorrhagiae  
and Patoc*
Australis, Ballum, Bataviae, Bratislava, Broomi, 
Canicola, Coxi, Cynopteri, Grippotyphosa, 
Haemolytica, Khorat, Paidjan, Pomona, Pyrogenes, 
Rachmati, Saxkoebing and Sejroe 
5.4 10
USA – Iowa 139 Bratislava*, Grippotyphosa, 
Hardjo, Icterohaemorrhagiae 
and Pomona
Canicola 8.6 8
Germany – Munich 215 Australis*, Autumnalis, 
Bratislava, Copenhageni  
and Grippotyphosa 
Canicola, Pomona and Saxkoebing 17.9 11
Caribbean island  
of St Kitts
50 Cynopteri and Pomona Alexi, Australis, Autumnalis, Bataviae, Ballum, 
Borincana, Bratislava, Canicola, Celledoni, Cynopteri, 
Djasiman, Georgia, Grippotyphosa, Hardjo, 
Icterhemorrhagiae, Javanica, Mankarso, Pomona, 
Pyrogenes, Tarassovi and Wolffi
4 21
Brazil – Lago Grande 43 Andamana and Patoc Autumnalis, Australis, Bataviae, Bratislava, Butembo, 
Canicola, Castellonis, Copenhageni, Cynopteri, 
Grippotyphosa, Guaricura, Hardjo-prajitno, 
Hebdomadis, Icterohaemorrhagiae, Javanica, 
Panama, Pomona, Pyrogenes, Shermani, Tarassovi, 
Whitcombi and Wolffi
4.7 22
Mexico – Mérida 13 Australis and Canicola* Autumnalis, Bratislava, Grippotyphosa, Hardjo, 
Icterohaemorrhagiae, Pyrogenes, Panama, Pomona, 
Tarassovi and Wolffi 
23.2 23
Iran – Mashhad 147 Hardjo*, Icterohaemorrhagiae 
and Pomona 
Autumnalis, Ballum, Canicola and Grippotyphosa 12.9 12
Taiwan – Southern 
Taiwan
225 Australis, 
Icterohaemorrhagiae, 
Javanica, Pyrogenes  
and Shermani*
Autumnalis, Bataviae, Canicola, Panama, Pomona 
and Tarassovi
9.3 13
Canada – Quebec 240 Bratislava, Grippotyphosa, 
Icterohaemorrhagiae and 
Pomona*
Canicola and Hardjo 10.8 14
Chile – Valdivia, 
Osorno, Paillaco  
and San Pablo
124 Autumnalis*, Bataviae  
and Canicola
Ballum, Hardjo, Icterohaemorrhagiae and Pomona 25.2 15
Serbia – Belgrade 161 Australis*, Bratislava, 
Canicola, Grippotyphosa 
Pomona* and Pyrogenes 
Autumnalis, Bataviae, Icterohaemorrhagiae  
and Sejroe
26.7 24
Canada – Quebec 40 Autumnalis and Bratislava* Canicola, Grippotyphosa, Icterohaemorrhagiae  
and Pomona
25 25
Reunion Island 30 Panama Australis, Autumnalis, Bataviae, Canicola, 
Castellonis, Cynopteri, Grippotyphosa, Hardjo-bovis, 
Hebdomadis, Icterohaemorrhagiae, Copenhageni,  
Pomona, Pyrogenes, Sejroe and Tarassovi 
26.6 26
Iran – Ahvaz 102 Australis and Ballum* Canicola, Grippotyphosa, Hardjo, 
Icterohaemorrhagiae and Pomona
4.9 27
USA – Massachusetts 63 Autumnalis*, Bratislava, 
Icterohaemorrhagiae  
and Pomona 
Canicola, Grippotyphosa and Hardjo 4.8 20
Spain – Andalucia 53 Ballum and 
Icterohaemorrhagiae* 
Australis, Autumnalis, Bataviae, Bratislava, Canicola, 
Grippotyphosa, Hardjo, Hebdomadis, Pomona, 
Saxkoebing, Sejroe and Tarassovi
14 16
Greece – Thessaloniki 99 Ballum, Bataviae, Bratislava, 
Canicola, Panama, Pyrogenes 
and Rachmati* 
Hebdomadis, Panama and Pomona 33.3 17
Scotland – Glasgow 87 Autumnalis, Hardjo-bovis*  
and Icterohaemorrhagiae
Autumnalis, Bratislava, Ballum, Canicola, Cynopteri, 
Grippotyphosa, Javanica, Pomona and Tarassovi
9.2 18
New Zealand – North 
Island
225 Balcanica, Ballum, Canicola, 
Copenhageni*, Hardjo* and 
Pomona
Australis, Bataviae, Javanica, Pyrogenes and 
Tarassovi
8.8 28
*Most prevalent serovar reported in the study
Table 1 Prevalence data for leptospirosis in cats diagnosed by microscopic agglutination test
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Table 2 summarises the scant research that has 
been carried out in cats in different countries 
to determine the prevalence of Leptospira 
DNA shedding in urine. In these studies,  
the prevalence ranged from 0% to 67.8%,  
with no clear association with clinical disease. 
The prevalence may differ depending on the 
geographical location and the PCR-selected 
primers, among other factors. 
 
Pathogenesis 
 
Depending on the host and infecting serovar, 
leptospiral infection may cause a spectrum of 
syndromes from asymptomatic carriage to 
fulminant, acute disease.3 Reports of clinical 
disease due to Leptospira species in pet cats are 
scarce.  
Leptospires can enter the body through cuts 
and abrasions, mucous membranes, such as 
the conjunctiva, or through moist, weakened 
skin. The bacteraemia lasts around 7 days. 
The pathogenesis of the disease in cats 
remains unknown, although it is assumed  
to be similar to that in humans and dogs37 
(Figure 2). Acute clinical disease occurs with 
the bacteraemic phase of the disease.1,2,38  
It is seen mainly in young incidental hosts  
and is usually associated with haemolysin- 
producing bac teria, such as the Ictero -
haemorrhagiae or Pomona serogroups, which 
cause haemolytic disease, haemo globinuria, 
jaundice and, in severe cases, death.3 After 
lepto spires have reached a critical level in the 
blood, clinical signs appear due to the action 
of lepto spiral toxins or toxic cellular compo-
nents.1,2,38 Organ damage occurs as a result of 
lepto spires replicating and inducing cytokine 
production and by direct invasion of inflam-
matory cells.3  
The primary lesions develop in the endo -
thelium of the small blood vessels, leading  
to localised ischaemia, and resulting in  
renal tubular necrosis, among other target 
organ damage (Figure 2). Renal colonisation 
occurs in most infected animals because  
the bacteria replicate and persist in the cells  
of the renal tubule epithelium. This multi -
plication process causes the release of 
cytokines and the recruitment of inflam -
matory cells, which trigger nephritis.1,2,38 
Chronic interstitial nephritis, which may 
result in chronic renal damage, has been 
described in cats infected with lepto spires.16 
After 10 days of infection, lepto spires  enter 
the tubular lumen and are eliminated in  
the urine over a period of days to months.1,2,38 
The duration of elimination via the urine  
and its intensity varies from species to species 
and animal to animal, and depends on the 
infecting serovar;3 precise information on 
these aspects is currently unavailable in cats.  
As mentioned earlier, cats can act as  
carrier hosts, not developing clinical disease, 
but shedding bacteria into the environment  
in their urine. An epidemiological study  
has confirmed the presence of leptospiral 
DNA in the urine of cats for more than  
8 months after infection, with little or no  
association with disease.11 However, this does 
not rule out the possibility that infected  
animals could develop kidney disease at a 
later stage. The development of the carrier 
state and the specific mechanisms required for 
leptospires to enter the lumen of the proximal 
renal tubules, adhere to renal epithelial cells, 
evade antibodies in the filtrate and acquire  
the nutrients they need to replicate are not 
well understood.3  
Leptospiral pulmonary haemorrhage syn-
drome (LPHS) has been recognised in people 
and dogs. This syndrome may be present  
in 70% of dogs infected with leptospires.39  
The clinical signs associated with canine 
LPHS are mainly acute and findings corre-
spond to severe alveolar and subpleural 
Cats can act as carrier hosts,  
not developing clinical disease, but shedding 
bacteria into the environment in their urine.
Although the pathogenesis of feline leptospirosis is not yet well understood,  
it is assumed to be very similar to that in humans and dogs.
Location n Gene target/primer set Prevalence (%) Reference
Reunion Island 172 rrs2, lipL32 and lipL41 0.6 35
Thailand – 13 
locations
260 lipL32 0.8 10
Algeria – Algiers 107 rrs (16S) and hsp 0 36
Germany – 
Munich
215 lipL32 3.30 11
Australia – 
Christmas Island
59 23S 42.4 33
Canada – 
Quebec
240 G1 and G2 and  
B64-I/B64-II
3.33 14
Réunion Island 30 lipL32 26.6 26
Taiwan – 
Southern Taiwan
225 G1/G2 and Leptospira rrs 
(16S)
67.8 13
Table 2 Summary of current research on prevalence of urinary 
shedding of Leptospira DNA in cats
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haemorrhages, which cause an associated 
dyspnoea. While, to date, LPHS has not been 
described in cats, chronic liver inflammatory 
infiltration, fibrosis and multifocal hepatic 
necrosis have been reported.14,16,31 Damage to 
organs including the spleen, eyes, meninges, 
muscle and placenta has also been reported in 
species other than cats.2,3,40 
Figure 2 Proposed pathogenesis of leptospirosis in cats. The figure depicts the transmission mechanisms through which a cat can 
become infected by Leptospira species: preying on rodents, sharing the environment with farm animals that shed the bacteria in 
urine, or through standing water containing bacteria. Once the animal has become infected it suffers a period of bacteraemia of 
approximately 7 days and leptospires can be identified in blood. The main target organs in cats are the kidney and the liver; 
lungs, brain and eyes may also be affected, especially in dogs. Replication of leptospires occurs in the kidney leading to urinary 
bacterial shedding. Image ©Biorender
The  
presence of 
another cat  
in the 
household 
significantly 
increases  
the risk of 
seropositivity 
for 
leptospirosis.
The virulence mechanisms of leptospires and the 
intrinsic factors of the host that determine the 
result of infection remain poorly understood. 
Recent mutagenesis studies in animal models of 
acute infection and of renal colonisation have 
demonstrated that specific genes and proteins, 
among them lipoproteins LipL32 and LipL41 and 
LigB adhesin, are present in pathogenic Leptospira 
species, but are not necessary for virulence.3,41,42 
Loa22, an outer membrane protein containing a  
C-terminal OmpA domain, plays an indirect role  
in the virulence of Leptospira species.43 Changes 
in motility through modifications in or mutations  
of genes involved in flagellar structure also play a 
role in the specific virulence of lepto spires.44,45  
Adhesion to host tissues appears to be a pre -
requisite for successful infection; however, genet-
ic studies have not confirmed a definitive role for 
many adhesins in the pathogenesis of Leptospira 
species.3 With regard to the survival of leptospires 
in vivo, it has been suggested that pathogenic 
lepto spires undergo receptor-mediated endo -
cytosis46,47 and are able to survive inside  
macro phages.48 Pro d uction of pro-inflammatory 
cytokines and chemokines is more pro lific in  
animal species susceptible to severe lepto spirosis 
compared with resistant animal species.49 
Pathogenic leptospires are resistant to the bacte-
ricidal activity of complement, while saprophytic 
leptospires are highly susceptible.41,50,51 The abili-
ty to acquire iron in vivo is a key virulence property 
for most bacterial species. Pathogenic lepto spires 
possess haem oxygenase (HemO), which facili-
tates the acquisition of iron from heme, the  
major source of iron in the mammalian host.52,53 
However, no conclusive results were obtained in 
relation to attenuation of virulence of leptospires 
in a study using a HemO mutant.54  
Mutagenesis studies have also demonstrated 
that several stress response genes, which are 
upregulated with bacterial transition from the 
environment to the host, increase their suscepti-
bility to oxidative stress and therefore render  
the bacteria less virulent.55–57 In the same way,  
the inactivation of Mce, a homologue of the 
mycobacterial mammalian cell entry protein in 
lepto spires, has been found to result in a signifi-
cant reduction in virulence.58 
 V i r u l e n c e  m e c h a n i s m s  a n d  h o s t  f a c t o r s
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with antibodies against Leptospira species have 
been found to have signs associated with renal 
disease and/or histopathological evidence  
of renal inflammation.14,16,30,35,59 As in dogs, 
leptospirosis in cats can cause acute kidney 
injury that leads to chronic kidney disease.19,60 
Lesions in the liver of affected cats have been 
reported less commonly than in dogs.11,18,29,31,32 
Tables 3–5 collate information from several 
papers that detail the clinical signs in cats  
at the time of presentation, the laboratory  
test used for diagnosis and the Lepto­spira­
serovars­involved. The cases have been divid-
ed into cats with acute disease (Table 3), those 
identified as chronic carriers (Table 4) and 
those with a history of exposure (Table 5). 
Diagnosis 
 
Clinical signs 
In cats, clinical signs are, at most, mild, 
despite the presence of leptospires in the 
blood and urine.  
Clinical signs reported in infected cats 
(based on confirmation by MAT and/or PCR) 
include polyuria, polydipsia, haematuria, 
uveitis, lameness, lethargy, anorexia, weight 
loss, ascites, vomiting, diar rhoea, pain on han-
dling, and inflammatory lesions on the skin 
and digits.11,14,17,18,25,30–32,59 Pathological find-
ings reported in these animals include the 
presence of haemorrhagic or straw-coloured 
thoracic and peritoneal fluids.31,18 Some cats 
Reference Serovar(s) Clinical signs Diagnosis MAT PCR
P
ro
sp
ec
tiv
e 
st
ud
y
11 Australis Seizures Not reported + +
11 Australis, Bratislava and Copenhageni Acute diarrhoea Not reported + +
14 Bratislava, Grippotyphosa, Icterohaemorrhagiae 
and Pomona
Not reported AKI 4+ NP
18 Autumnalis, Hardjo, and Icterohaemorrhagiae Not reported AKI 8+ NP
C
as
e 
re
po
rt
32 Saxkoebing Vomiting and diarrhoea, hyperaesthesia  
and painful on handling
AKI – 
leptospirosis
+ +
31 Grippotyphosa, Hardjo, Icterohaemorrhagiae  
and Pomona
Polyuria and polydipsia AKI – 
leptospirosis
+ NP
31 Bratislava, Grippotyphosa and Pomona Polyuria, polydipsia, haematuria and lameness AKI – 
leptospirosis
+ NP
31 Autumnalis, Bratislava, Grippotyphosa  
and Pomona
Comatose AKI – 
leptospirosis
+ +
30 Autumnalis and Pomona Haematuria Leptospirosis + +
MAT = microscopic agglutination test; + = positive; – = negative; AKI = acute kidney injury; NP = not performed; 4+, 8+ = number of positive cats 
in the study
Table 3 Clinical signs of leptospirosis in cats based on published studies of acute disease
Reference Serovar(s) Clinical signs Diagnosis MAT PCR
P
ro
sp
ec
tiv
e 
st
ud
y
11 Australis and Bratislava Asymptomatic Incidental infection (routine  
health check)
+ +
11 Grippotyphosa Not reported Mast cell tumour in spleen and liver + +
11 Not determined Not reported Foreign body in pharynx (grass) – +
11 Grippotyphosa Not reported CKD and abdominal mass + +
11 Australis, Autumnalis, Bratislava 
and Copenhageni
Chronic diarrhoea Not reported + +
14 Bratislava, Copenhageni, 
Grippotyphosa and Pomona 
Not reported CKD 13+ 6+
14 Bratislava, Grippotyphosa, 
Icterohaemorrhagiae and 
Pomona
Not reported Incidental infection (routine  
health check)
9+ 2+
16 Icterohaemorrhagiae Kidney: Chronic interstitial nephritis. 
Chronic inflammatory infiltrate 
(macrophages and lymphocytes) 
Liver: Chronic inflammatory infiltration 
Not reported + NP
16 Canicola Asymptomatic Not reported + NP
MAT = microscopic agglutination test; + = positive; – = negative; CKD = chronic kidney disease; NP = not performed; 13+, 6+, etc = number  
of positive cats in the study
Table 4 Clinical signs of leptospirosis in cats according to published studies of chronic carrier cases
Clinical signs in 
cats are mild or 
absent despite 
the presence  
of leptospires  
in the blood 
and urine. 
216_228_Murillo2.qxp_FAB  03/02/2020  12:44  Page 221
 222 JFMS CLINICAL PRACTICE
RE V IEW  /  Leptospirosis in cats
Reference Serovar(s) Clinical signs Diagnosis MAT PCR
P
ro
sp
ec
tiv
e 
st
ud
y
9 Ballum, Bataviae and Javanica Not reported Feline upper 
respiratory disease
+ NP
15 Autumnalis, Bataviae, Canicola  
and Grippotyphosa
Asymptomatic Incidental infection 
(routine health check)
10+ NP
24 Australis, Bataviae, Bratislava, 
Canicola, Grippotyphosa, 
Icterohaemorrhagiae, 
Pyrogenes, Pomona and Sejroe
Asymptomatic Incidental infection 
(neutering)
43+ NP
25 Autumnalis and Bratislava Not reported CKD + NP
25 Autumnalis and Bratislava Polyuria and polydipsia Not reported + NP
25 Autumnalis and Bratislava Not reported Hepatic lipidosis 2+ NP
25 Autumnalis and Bratislava Asymptomatic Not reported 3+ NP
27 Australis and Ballum Asymptomatic Not reported 5+ NP
16 Icterohaemorrhagiae Kidney: Chronic interstitial nephritis. Chronic 
inflammatory infiltrate (macrophages, lymphocytes  
and plasma cells). Proliferative glomerulonephritis 
Liver: Multifocal hepatic necrosis. Chronic inflammatory 
infiltrate (lymphocytes and plasma cells)
Not reported + NP
16 Ballum Kidney: Chronic interstitial nephritis. Chronic 
inflammatory infiltrate (macrophages and plasma cells)
Not reported + NP
16 Ballum Asymptomatic Not reported + NP
16 Icterohaemorrhagiae Kidney: Chronic interstitial nephritis. Chronic 
inflammatory infiltrate (macrophages and lymphocytes) 
Not reported + NP
17 Rachmati Asymptomatic Not reported 15+ NP
17 Rachmati Not reported Various chronic 
diseases
18+ NP
R
et
ro
sp
ec
tiv
e 
st
ud
y
59 Bratislava and 
Icterohaemorrhagiae 
Not reported CKD – azotaemia 4+ NP
59 Bratislava and 
Icterohaemorrhagiae 
Not reported CKD – non-azotaemia 8+ NP
MAT = microscopic agglutination test; + = positive; – = negative; CKD = chronic kidney disease; NP = not performed; 10+, 43+, etc = number of 
positive cats in the study
Table 5 Clinical signs of leptospirosis in cats based on published studies of animals with a history of exposure
Polyuria, polydipsia, haematuria, uveitis, laminitis, lethargy, anorexia, weight loss, 
vomiting and diarrhoea, painful handling, and inflammatory lesions on skin and foot 
digits are some of the clinical signs reported in affected cats. 
Clinicopathological data 
Table 6 summarises some of the most common 
clinicopathological abnormalities associated 
with leptospirosis in cats. 
 
Complete blood count  
Leukocytes can fluctuate according to the 
stage and severity of infection. Leuko penia is 
a possibility during lepto spiraemia, evolving 
to leukocytosis owing to neutrophilia with a 
left shift. In advanced states, leuko cyte counts 
may be in the range of 16.5–45 x 109/l (refer-
ence interval 2.75–11.75 x 109/l).18,19,60,61 
 
Serum biochemistry  
Urea and creatinine concentrations are 
increased in 80–90% of cases of canine  
lepto spirosis.60 Most infected cats present 
with azotaemia at the time of diagnosis.  
The increase is usually moderate to sev -
ere.11,14,25,31,32,59 In affected dogs, serum liver 
enzyme (alkaline phosphatase [ALP] more 
commonly than alanine aminotransferase 
[ALT]) and total bilirubin increases are associ-
ated with liver dys function.38,40,60 Conversely, 
in feline lepto spirosis these increments are  
not as characteristic, and only slight increases 
have been reported.11,18,25,31,32 Leptospire tox-
ins inhibit Na+K+-ATPase activity in the 
epithelial cells of the renal tubules in cats and 
dogs, which can lead to significant renal  
losses of electro lytes, resulting in severe hypo -
 ka laemia.60 In cats, increases in serum phos -
phorus concentration have been reported, 
probably associated with a decrease in the 
glomerular filtration rate.31 
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MAT results are strongly dependent on labo-
ratory quality control, and there is con siderable 
inter-laboratory variability.63 Prac titioners are 
encouraged to submit diagnostic samples to 
laboratories that adhere to a proficiency 
scheme.64 Test interpretation may be more reli-
able in cats than in dogs because no interfer-
ence with vaccine antibodies exists as cats  
are not vaccinated.37 Furthermore, laboratory-
reared young adult specific pathogen-free cats 
infected with Borrelia­burgdorferi did not form 
antibodies against Leptospira­species as a cross-
reaction.59 The authors of that study suggest 
that positive Leptospira­ species MAT results 
from cats in the field are likely to reflect anti-
bodies against leptospires and not B­burgdorferi.  
Urine analysis  
Findings in dogs include isosthenuria or occa-
sionally hyposthenuria, glycosuria, protein-
uria, bilirubinuria, haematuria, pyuria and the 
presence of casts in fresh urine sediment.38,60 
In cats, hyposthenuria, haematuria and pro-
teinuria have been reported.30,31 Leptospires 
are not visible on routine fresh urinary sedi-
ment examination, as the size of the bacteria is 
below the resolution of light microscopy.19  
 
Ultrasonographic findings 
The few published reports of feline lepto -
spirosis describe renal ultrasonographic  
findings that are similar to those in canine  
leptospirosis, including a granular appear-
ance of the kidney, enlarged kidneys with  
a cortex that is thinner than the medulla,  
a slightly hyperechogenic renal cortex and  
a decrease in the definition of the corti-
comedullary junction.31,32 Het erogeneity in the 
pancreatic and liver paren chyma has also 
been reported in one case.32 
 
Specific testing 
Laboratory diagnosis of leptospirosis in veteri-
nary medicine is usually based on the demon-
stration of serum antibodies by MAT and 
ELISA, and/or isolation of Leptospira­ DNA 
from blood and urine by PCR. Bacterial cul-
ture of blood and/or urine is not widely used 
because it is time consuming. Specific diag-
nostic tests that are available for cats are MAT 
and PCR. 
 
Microscopic agglutination test 
Determination of antibody titre by MAT is  
the recommended technique for leptospirosis 
diagnosis, as MAT reactivity to a serovar sug-
gests exposure to a serovar belonging to the 
corresponding serogroup (though not neces-
sarily to the specific serovar tested).62 The selec-
tion of the serogroups and the serovars to be 
evaluated depends on the geographical loca-
tion of the patient’s likely exposure. Antibodies 
(IgM and IgG) are detected at around 15 days 
post-infection by MAT.3 Little information is 
available on the duration of these antibodies 
in the blood of cats. Clinical interpretation 
should always be based on the results of paired 
serum titres, and it is worth noting that some 
infected animals may produce a result that is 
lower than the widely accepted minimum sig-
nificant titre result of 1:100.3 It is even possible 
that seroconversion in cats is expressed at a 
lower titre compared with dogs.59  
MAT results are strongly dependent on quality control procedures  
in the laboratory. Practitioners are encouraged to submit diagnostic 
samples to laboratories that adhere to a proficiency scheme. 
Finding Clinical course
Affected/sampled 
cats
Haematology Non-regenerative 
anaemia
Chronic carrier 2/19 (10.5%)
Haemoconcentration Acute disease 2/19 (10.5%)
Neutropenia Acute disease 1/19 (5.2%)
Neutrophilia Acute disease 2/19 (10.5%)
Leukocytosis with  
left shift
Acute disease 2/19 (10.5%)
Thrombocytopenia Acute disease 1/19 (5.2%)
Biochemistry Hypoalbuminaemia Acute disease 2/2 (100%)
Azotaemia Acute disease and 
chronic carrier
9/19 (47.4%)
Liver enzymes increased Acute disease 6/8 (75%)
Hyperglycaemia Acute disease 1/2 (50%)
Hyperphosphataemia Acute disease 1/1 (100%)
Bicarbonate decreased Acute disease 1/1 (100%)
Urine analysis Low USG Acute disease and 
chronic carrier
3/5 (60%)
Proteinuria Acute disease 3/6 (50%)
Haematuria Acute disease 2/6 (33.3%)
Renal and red cell casts Acute disease 1/5 (20%)
Serological 
test
FeLV/FIV negative Acute disease 5/5 (100%)
USG = urine specific gravity; FeLV = feline leukaemia virus; FIV = feline 
immunodeficiency virus
Table 6 Clinicopathological findings in 19 cats diagnosed 
with leptospirosis11,18,30–32
Several studies have confirmed renal 
carriage of Leptospira species in cat 
populations, which means cats could be a 
chronic reservoir host for the bacteria and a 
possible risk factor for human infection.
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ELISA and rapid immunodiagnostic 
screening tests 
ELISAs used for leptospirosis identify the pres-
ence of leptospiral antibodies (specific IgM class 
antibodies) earlier than MAT, at between 4–6 days 
post-infection.3 The main advantages of ELISA 
compared with MAT are, in the authors’ opin-
ion, the stability of antigenic preparations and 
the genus specificity, meaning all types of lep-
tospires can be diagnosed with a single antigenic 
preparation, irrespective of the causal serovar.65 
In dogs, a combination of ELISA plus MAT is 
recommended for lepto spirosis diagnosis.19  
Rapid patient-side tests for leptospirosis diag-
nosis were developed almost a decade ago.66 
Curtis et al performed a recombinant LipL32-
based rapid in-clinic ELISA (SNAP Lepto) for 
the detection of antibodies against Leptospira­
species­ in dogs in 2015.67 Neither of the tests 
distinguish between serovars, nor do they pro-
vide a titre magnitude. The first test66 is based 
on the detection of Leptospira-specific IgM and 
has demonstrated a sensitivity and specificity 
of 100% and 95.3%, respectively. It can there-
fore detect dogs with clinically suspected acute 
leptospirosis. Dogs previously vaccinated or suf-
fering from an acute but subclinical infection can 
also produce positive results. A LipL32-based in-
clinic ELISA for the rapid detection of Leptospira-
specific antibodies in dogs is not IgM specific, 
but the study authors considered it a convenient 
tool to assess Leptospira antibody status in dogs.67  
Neither rapid test techniques, nor ELISA, to 
diagnose leptospirosis in cats have yet been 
developed. 
PCR  
PCR directly identifies leptospiral DNA. It 
does not determine the infecting serogroup  
or serovar, but it can indicate the Leptospira 
species. The test can be performed on blood, 
urine, cerebrospinal fluid and body tissues.  
In cases of acute leptospirosis, this would be 
the test of choice to perform on blood and 
urine in cats. Compared with culture, PCR 
gives fast results, contributing to an early 
diagnosis.65 Real-time PCR techniques are rec-
ommended, due to their greater sensitivity 
and specificity. Genes that have more than  
one copy in the genome, such as lig or rrs,­
should be selected with the aim of increasing 
the sensitivity of the technique. Genes present 
only in the pathogenic species can also be 
added as they will increase the specificity of 
the test.68  
A positive PCR result means that leptospiral 
DNA is present in the sample. In acute  
infections or in chronic carriers, the test  
would be positive in urine, indicating that 
bacterial DNA is being shed. However,  
negative results in blood and urine do not  
rule out lepto spirosis, as leptospiraemia is 
transient (only occuring in the initial phases  
of the disease); also results are usually  
negative if the cat has received antibiotic  
therapy,19,60 and shedding in urine can be 
intermittent.3 In one report, leptospires were 
cultured from cat urine and the results were 
confirmed by PCR,34 suggesting that cats  
can shed living Leptospira­ bacteria, not just 
their DNA.  
ELISA  
and rapid 
patient-side 
tests for 
Leptospira 
species 
diagnosis in 
cats have not 
yet been 
developed.
MAT = microscopic agglutination test
Diagnostic approach for a cat with suspected leptospirosis
POSITIVE
NO
NO
LEPTOSPIROSIS LEPTOSPIROSIS
Rule out 
leptospirosis
YES
YES
NEGATIVE
History of exposure, 
and clinical findings 
and clinicopathological 
abnormalities 
consistent with 
leptospirosis
Real-time PCR on 
blood and urine 
Supportive therapy with 
intravenous ampicillin while the 
patient is stabilised. Doxycyline 
oral suspenion for 6 weeks. 
Then perform real-time PCR on  
urine to rule out carrier status 
Antibodies, paired 
samples (2 weeks apart), 
seroconversion
Perform MAT 
Blood  
1. Antimicrobial therapy prior to sampling 
and/or 
2. Sampling after leptospiraemia (>7 days) 
Urine 
1. Antimicrobial therapy prior to sampling 
and/or 
2. Sampling before leptospiruria (<10 days) 
and/or 
3. Intermittent Leptospira DNA shedding (>10 days) 
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Treatment 
 
Supportive therapy  
Intravenous fluids should be given to  
affected animals to correct the electrolyte  
fluid imbalance. The use of centrally acting 
antiemetics and the parenteral administration 
of gastric protectors is recommended in cats 
that develop associated renal failure. Pain 
management is particularly important in the 
early stages of the disease to treat painful 
swollen kidneys, muscle, joints and gastro -
intestinal tissue.19  
A 2-year-old intact male domestic shorthair cat, 
showing lethargy and anorexia for 5 days, was 
presented for investigation.  
 
Case work-up The cat 
was an indoor–outdoor 
animal with a history of 
hunting small rodents. 
Vaccinations were current. 
On admission, the cat was 
quiet and depressed. On 
physical examination, body 
temperature was 39.7ºC 
and the cat’s mucous 
membranes were pale and 
dry. Heart rate was 180 beats per minute and pulse strength 
was normal; no murmurs or gallop rhythms were detected. 
Clinical dehydration was estimated to be 7%. There were no 
other remarkable findings upon physical examination. Owing  
to the non-specific clinical signs, blood samples were 
collected for haematology, biochemistry and feline leukaemia 
virus (FeLV)/feline immunodeficiency virus (FIV) testing. A urine 
sample was obtained by cystocentesis for complete urine 
analysis. Clinical pathology results are shown in the table.  
Mild leukocytosis with mature neutrophilia and 
thrombocytopenia were observed. Serum biochemistry profile 
showed a mild uraemia, increase in ALT and hyperproteinaemia 
(mainly due to an increase in the globulin fraction). FeLV 
antigen and FIV antibody testing were negative (IDEXX  
SNAP Combo Test). Most of the clinical pathological  
changes were suspected to be due to dehydration. However, 
thrombocytopenia and leukocytosis suggested a possible 
infectious origin. Ancilliary tests, including an abdominal 
ultrasound examination and thoracic radiography, were 
performed. The results were unremarkable.  
Given the patient’s predation habits, leptospirosis was 
considered and PCR (blood and urine) was performed. In 
addition, serum was serologically examined by MAT against 
eight Leptospira serovars: Australis, Autumnalis, Canicola, 
Grippotyphosa, Icterohaemorrhagiae, Javanica, Pomona  
and Sejroe. MAT serology for leptospirosis was negative.  
 
Diagnosis Blood PCR for leptospirosis was positive and urine 
PCR was negative.  
Courtesy of Fundaciò Hospital Clínic 
Veterinari, Universitat Autònoma de 
Barcelona, Spain
 C a s e  n o t e s
Complete blood count
Result RI
RBCs (x 1012/l) 6.2 6–10.2 
Hb (g/dl) 10.5 9–15 
HCT (l/l) 0.3 0.3–0.5 
MCV (fl) 47.2 41–53 
MCHC (g/dl) 36 30–34 
Leukocytes (x 109/l) 18.2 5.0–15.0 
Lymphocytes (x 109l) 5.8 1.4–6.1 
Monocytes (x 109/l) 1.8 0.1–0.6 
Band neutrophils  (x 109/l) 0 0–300 
Segmented neutrophils (x 109/l) 12.0 2.5–11.3 
Platelets (x 109/l)* 115 200–600 
Serum biochemistry (selected data)
Result RI
Albumin (g/l) 24.8 23–34 
Globulins (g/l) 44.0 26–38 
Total proteins (g/l) 96.9 54–78 
Creatinine (µmol/l) 91 44.2–132.6 
Urea (mmol/l) 8.6 3.32–8.3 
ALT (UI/l) 51.4 <50 
Urine analysis (cystocentesis) 
Result
Specific gravity >1.050 
pH 6
Nitrite Negative 
Protein Negative
Glucose Negative 
Ketones Negative 
Bilirubin Negative
Blood No abnormalities identified 
Sediment Moderate fat droplets 
UPC 0.23
*Only mild platelet aggregates were observed on blood smear 
RBCs = red blood cells; Hb = haemoglobin; HCT = haematocrit;  
MCV = mean cell volume; MCHC = mean cell haemoglobin 
concentration; ALT = alanine aminotransferase; UPC = urine 
protein:creatinine concentration; RI = reference interval
Clinical pathology results 
Continued on page 226
The prognosis depends principally on the severity of any organ damage.  
In dogs that develop LPHS, the prognosis is usually poor since the animal is 
in acute respiratory failure with associated dyspnoea resulting from damage 
to the small pulmonary vessels, as described earlier; LPHS is one of the most 
common leptospiral-associated causes of death in dogs. The prognosis  
is also poor for affected animals that develop acute renal injury unless 
haemodialysis is available.60  
In cats with mild clinical signs and no severe organ damage, response to 
specific antimicrobial therapy and outcome are good.30–32 Cats that survive 
acute renal failure, and especially those treated in the chronic phase of  
leptospirosis, may develop renal damage as a consequence of the initial  
condition, and this may be permanent. 
 P r o g n o s i s
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study suggest further work is needed before a 
vaccine against Leptospira­species for cats can 
be considered. 
Given the current lack of a vaccine, the best 
way to avoid infection in cats is via prevention 
of exposure. Cats that are kept indoors have a 
lower risk of being infected.37 Prevention of 
predation opportunities and avoidance of 
contact with stagnant water, urine from infect-
ed animals and dogs at risk of clinical lep-
tospirosis is recommended.6,30,31,37 For cats 
that share an environment with a positively 
diagnosed animal, doxycycline can be given 
at 5 mg/kg PO q12h or at 10 mg/kg PO q24h 
for 2 weeks.19,60 
 
Enteral feeding tubes are highly recommend-
ed in cats with anorexia, until they can feed 
themselves in a self-sufficient manner, min-
imising the risk of secondary complications.38 
 
Antimicrobial therapy  
The antimicrobial therapy suggested in cats is 
based on the treatment recommended for 
dogs. Intravenous ampicillin may be the 
antibiotic of choice while the patient is sta-
bilised. Once the animal is stable, 6 weeks of 
doxycycline oral suspension has been sug-
gested in order to eliminate the carrier state.37 
Monohydrate salt of doxycycline, which is less 
irritating to the cat’s oesophagus than hyclate 
or hydrochloride doxycycline salt, is market-
ed as tablets or suspension. Doxycycline 
mono hydrate tablets should be administered 
immediately before a meal or with a treat in 
order to avoid secondary oesophagitis.69,70 
 
Prevention 
 
There is no commercial vaccine available for 
cats. However, one study has shown that cats 
can produce antibodies (of lower titre magni-
tude than vaccinated dogs) when experimen-
tally inoculated with a commercial dog  
vaccine (containing four different serovars).59 
The follow-up time for the animals was 42 
days, at which point only one animal main-
tained antibody levels. The authors of that 
What this case demonstrates:  
✜ While leptospirosis is an uncommon infectious disease in cats, practitioners should consider leptospirosis as a differential 
diagnosis in cats that hunt small rodents. 
✜ At the time of admission, clinical pathological data in sick cats are not always characteristic of the disease, as in this case.  
✜ For acute infections, PCR on blood and urine is the first-choice test to perform; MAT antibody titres are likely to be 
negative or low at that point, and seroconversion is not expected until 15 days post-infection. 
✜ Leptospirosis is a zoonosis and special handling methods are needed in these cases: (1) avoiding contact with the cat’s 
urine and wearing gloves when cleaning the litter box; (2) using disinfectants to clean the cat’s litter box as well as any 
other areas where the cat urinates; (3) preventing the cat from going outside to urinate in the environment; and (4) always 
washing hands after handling the cat. 
✜ Owing to the zoonotic potential of leptospires, prophylactic treatment of other pets in the same household that may  
have been exposed to leptospires in the environment is recommended. 
✜ When a diagnosis of leptospirosis is made, veterinarians should inform pet owners of the zoonotic risk of  
Leptospira bacteria, and recommend medical attention if any family member develops signs of illness consistent  
with leptospirosis.
Treatment and outcome The cat was maintained  
on fluid therapy and antimicrobial therapy with ampicillin  
(20 mg/kg IV q12h) for 4 days. On day 4 of hospitalisation,  
ALT, creatinine and urea were re-checked; values were within 
reference intervals. On discharge, after receiving PCR blood 
results, doxycycline at 5 mg/kg PO q12h for 6 weeks was 
prescribed. Instructions were given to keep the animal 
confined during the next 6 weeks and isolated from other  
cats and dogs. The owners were advised to wear gloves while 
cleaning the litter box during this period, to use routine 
household disinfectants to clean the litter box and to wash 
their hands after handling their cat.  
Six weeks later, the cat had recovered completely and  
no abnormalities were observed upon physical examination.  
A further urine PCR was recommended in order to rule out  
a chronic carrier state, as well as a further MAT to assess 
seroconversion, but for economic reasons this was not 
approved by the owners. 
Continued from page 225
✜ Cats may act as chronic reservoir  
hosts of Leptospira bacteria and  
are a possible risk factor in the 
transmission and maintenance  
of leptospirosis, the most widespread 
zoonosis worldwide. 
✜ Research on leptospirosis 
should highlight the 
importance that cats  
have in the disease 
maintenance cycle. 
KEY POINTS
Doxycycline  
is advised to 
eliminate the 
carrier state.  
It should be 
administered 
as a 
monohydrate 
salt to avoid 
oesophagitis.
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